Literature DB >> 2752592

Serological diagnosis of HIV infection: incidence, outcome and significance of partial reactions found in western blot analysis.

J P Lantin1, I Graf, P C Frei.   

Abstract

Between May 1986 and April 1987 routine screening for anti-HIV antibody was performed by enzyme immunoassay (EIA) on 3344 serum samples. The 1160 samples found positive or borderline were further analysed in Western blot (Wb). We analysed the frequency of different patterns of 'intermediate' Wb reactions (1-3 'specific' bands) and tried to determine their significance by searching for possible modifications of the pattern of reaction a few months later. Of 1160 Wb, 461 were clearly positive, 489 negative and 210 'intermediate'. The latter consisted of: 92 sera with anti-p24 (associated or not), 23 with anti-gp 120 and 160, 16 with anti-p55, 12 with anti-p41, 10 with anti-p65, eight with anti-p17 and four with anti-p31. A non-specific pattern was observed in the remaining 45. Of these sera, 46% were obtained from high risk subjects, 38% from persons without risk and in 16% no reliable information was available. In 30 subjects (24 with p24 and 6 with p41), a second sample was obtained about three months later. The reaction persisted in nine, was replaced by another in five, and disappeared in 15. One subject with anti-p41 in the first sample became clearly positive. In one of the 15 samples with disappearance of the reaction, the antigen p24 was present as the only sign of HIV infection. Later samples of this subject showed clear seroconversion. In many subjects with and without risk of exposure to HIV, the Wb gives an intermediate pattern of reactions (1-3 specific bands), that does not permit definitive conclusion on one single sample. Later controls are therefore necessary. Most of these reactions do not correspond to HIV infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2752592      PMCID: PMC1541900     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  False-positive Western blot tests for antibodies to HTLV-III.

Authors:  D S Burke; R R Redfield
Journal:  JAMA       Date:  1986-07-18       Impact factor: 56.272

2.  Screening for HIV: can we afford the false positive rate?

Authors:  K B Meyer; S G Pauker
Journal:  N Engl J Med       Date:  1987-07-23       Impact factor: 91.245

3.  Asymptomatic blood donor with a false positive HTLV-III Western blot.

Authors:  M S Saag; J Britz
Journal:  N Engl J Med       Date:  1986-01-09       Impact factor: 91.245

4.  Blood donor sera with false-positive Western blot reactions to human immunodeficiency virus.

Authors:  G Biberfeld; U Bredberg-Rådén; B Böttiger; P O Putkonen; J Blomberg; P Juto; G Wadell
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

5.  Sensitivity of western blotting (compared with ELISA and immunofluorescence) during seroconversion after HTLV-III infection.

Authors:  J C Ulstrup; K Skaug; K J Figenschau; I Orstavik; J N Bruun; G Petersen
Journal:  Lancet       Date:  1986-05-17       Impact factor: 79.321

6.  Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs.

Authors:  J P Allain; Y Laurian; D A Paul; D Senn
Journal:  Lancet       Date:  1986-11-29       Impact factor: 79.321

7.  Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis.

Authors:  V C Tsang; J M Peralta; A R Simons
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

8.  Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.

Authors:  J Schüpbach; O Haller; M Vogt; R Lüthy; H Joller; O Oelz; M Popovic; M G Sarngadharan; R C Gallo
Journal:  N Engl J Med       Date:  1985-01-31       Impact factor: 91.245

9.  Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus.

Authors:  J M Lange; R A Coutinho; W J Krone; L F Verdonck; S A Danner; J van der Noordaa; J Goudsmit
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-25

10.  Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

Authors:  M G Sarngadharan; M Popovic; L Bruch; J Schüpbach; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  3 in total

1.  Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa.

Authors:  F Behets; A Disasi; R W Ryder; K Bishagara; P Piot; M Kashamuka; M Kamenga; N Nzila; M Laga; G Vercauteren
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

2.  Host-virus interaction as defined by amplification of viral DNA and serology in lentivirus-infected sheep.

Authors:  S J Brodie; L D Pearson; G D Snowder; J C DeMartini
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Evaluation of a line immunoassay for simultaneous confirmation of antibodies to HIV-1 and HIV-2.

Authors:  K Fransen; D E Pollet; M Peeters; I van Kerckhoven; G Beelaert; G Vercauteren; P Piot; G van der Groen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.